MARKET OVERVIEW- GLOBAL SINGLE DOMAIN ANTIBODY PLATFORM MARKET
Growing influence of preclinical testing in terms of drug discovery and overwhelming demand in terms of launching novel immunotherapies acts as a vital factor escalating the market growth. Moreover, growing advancements in pharmaceutical therapies and heightening medical research in terms of discovering novel innovative drugs is expected to act as a major factor driving the single domain antibody platform market. In addition to that, escalating usage of single-domain antibody platforms in applications like therapeutic development, research and development activities, and diagnostic laboratories will further create new opportunities for single domain antibody platform market.
Increasing medical research to develop innovative drugs coupled with rising advancement in pharmaceutical therapies such as personalized therapies and are key factors driving the single-domain antibody platform market. The growing advancements in medical research in discovering novel innovative drugs bringing more growth in single-domain antibody platform market. Rising research and development activities also play an important role in the growth of the single-domain antibody platform market. Moreover, the key market players are adopting growth strategies for increase their product portfolio of single domain antibody platform which eventually fueling the market growth.
In addition, single domain antibodies are highly successful against viral infections, including hepatitis C virus (HCV), influenza viruses, HIV-1 and enteric viruses. The installation of these antibody platforms enables cost-effectiveness and it help to shorten the span which is further driving the market growth in forecast period.
Increasing use of single-domain antibodies in various end-users including, biotechnology companies, pharmaceutical, diagnostic laboratories and clinical laboratories and research institute bringing growth opportunity in single domain antibodies platform market. Also, the growing investments across the single-domain antibody platforms market by a large number of firms and conglomerates owing to large ROI (return-on-investments) may bring immense growth opportunities for the single-domain antibody platforms market.
The market has major restraining factor like lack of skilled professional & high maintenance of antibodies. Stringent government regulations by various government bodies is expected to acts as a hurdler for the market growth over the forecast period. As not only end product but also the process, CQAs, antibodies, consumable cell lines, and equipment that went into production, has to gain approval from regulatory bodies.
MARKET GROWTH CHALLENGES
The production of VHHs makes use of biohazardous materials such as bacteriophages, plasmids, antibiotics and other. Accordingly, these materials should be need to carefully handled is another limitation for single-domain antibodies. This factor hampered the growth of market to major extent which has created a major challenges for the market growth. Also, lack of profession for single domain antibodies development is expected to be major hampering for the market growth over the forecast the period.
CUMULATIVE GROWTH ANALYSIS
The report provides in-depth analysis of global single domain antibody platform market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. With increasing demand for various single domain antibody platform in various applications has led the increasing demand for market and is expected to witness the growth at a CAGR at specific CAGR from 2021-2028.
SINGLE DOMAIN ANTIBODY PLATFORM MARKET SEGMENTAL OVERVIEW
The global single domain antibody platform market comprises of different market segment like platform type, animal source, application, end-user and geography.
SINGLE DOMAIN ANTIBODY PLATFORM MARKET BY PLATFORM TYPE
The Platform type studied in the global Single domain antibody platform market are
- Multi-specific single domain antibody
- Bispecific single domain antibody
- Multivalent single domain antibody
- Mono-specific single domain antibody
Bispecific segment is expected to most dominating in the single-domain antibody platform market. The IgG-like is one of the bispecific antibodies that help to purify and improve solubility, stability and affinity which is driving its demand in the market. Also, Bispecific single domain antibodies are capable of simultaneous binding to two different targets, are considered the most promising solution to increasing therapeutic activities. In addition to that, the key factor boosting the segment growth is increasing disease such as cancer, diabetes, alzhimers and it also include pneumonia and eye diseases across the globe.
SINGLE DOMAIN ANTIBODY PLATFORM MARKET BY ANIMAL SOURCE
The major type of animal source is used to produce single domain antibodies including
The camelid segment account largest share in the market. Camelid single domain antibodies are also known as VHHs and that are derived from the Camelidae family of mammals. Unlike other antibodies camelid antibodies lack a light chain and are composed of two identical heavy chains. The growing advancements in pharmaceutical therapies and medical research in discovering novel innovative drugs boosting growth for camelid single domain antibody market. In addition, Camelid offers ease of genetic engineering and low production cost as compared to other segment, due to this advantages offered by camelids antibodies it has become potential candidate used in antibody-based therapies.
SINGLE DOMAIN ANTIBODY PLATFORM MARKET BY APPLICATION
The application studied in the global Single domain antibody platform market are
- Diagnostic development
- Therapeutic development
- Research & development activities
The diagnostic development segment commanded largest share in the application segment of single domain antibody platform market. As antibodies are central in development methods from over decades. The antibodies are critical component of diagnostic as it used for detection of infections, recognition of allergies and the measurement of hormones and other biological marker in blood.
SINGLE DOMAIN ANTIBODY PLATFORM MARKET BY END-USERS
By End-Users, the single domain antibody platform includes key segment of
- Diagnostic laboratories
- Clinical laboratories
- Academic & research institutes
- Pharmaceutical & biotechnology companies
The pharmaceutical & biotechnology segment accounted largest share in the market. Increasing application of single-domain antibodies against viral infection, including hepatitis C virus, influenza viruses, HIV-1 and enteric viruses. Furthermore, growing advancements in pharmaceutical drug development process and heightening medical research in term of discovering novel innovative drugs is expected to increase the growth of single domain antibody platform market in pharmaceutical & biotechnology industry. In addition, with advancement in pharmaceutical therapies such as personalized therapies, increasing medical research and demand for advanced methods of preclinical testing is boosting the market growth.
SINGLE DOMAIN ANTIBODY PLATFORM MARKET BY GEOGRAPHY
The global single domain antibody platform market is studied for the following region
• North America
• Rest of the world (RoW)
North America is likely to witness rising demand for single domain antibody platform market due to increasing drug development activities and emergency departments, presence of key players, and rise healthcare expenditure in the North-America region. Rising awareness and initiatives by local government for research and development in this region boost the single domain antibody platform market growth. Also, Asia-Pacific is anticipated to hold second position in the market followed by North America. Asia-Pacific is likely to have growth at specific growth rate.
COVID-19 IMPACT ANALYSIS ON GLOBAL SINGLE DOMAIN ANTIBODY PLATFORM MARKET
The repercussions of the pandemic have been described in detail in this report. The varied observations made by the Axiom market researchers provide accurate information about each point surrounding the growth of the single-domain antibody platforms market. Report provides complete analysis of changes in the global market expenditure, economic and international policies on the supply and demand side. The report also studies the impact of the pandemic on global economies, international trade, business investments, and GDP and marketing strategies of key players present in the market.
COVID-19 has various impact in different countries depending on their cultural norms, mitigation efforts, and health infrastructure. The economies in low and middle-income countries is affected negatively due to loss of income, the shutdown of business, human and goods movement restrictions imposed by governments, de-globalization and breakdown of markets because of both demand shocks and supply constrain. The COVID-19 outbreak will have a negligible negative impact on the single-domain antibody platforms market.
The COVID-19 pandemic has positive impact on single-domain antibody platforms market. As the healthcare and life-sciences sector was allowed to operate without any restrictions even during the strict lockdown period. Various single-domain antibodies were developed and are currently in research mode for COVID-19 drugs. Thus, this factor will help in increasing the growth rate of the single-domain antibody platforms market.
COMPETITIVE LANDSCAPE ANALYSIS
The competitive landscape analysis of single domain antibody platform market is majorly focused on expanding the global growth of single domain antibody platform with new product innovation, business expansion, increasing presence of range of manufacturer operating in single domain antibody platform has led the growing demand for the market. Besides, the market offers range of products in different application to fulfill the required demand of consumer which is further contributing healthy growth in the market.
The key players studied in market are
- Creative BioLabs
- Synbio Technologies
- ProSci Incorporated
- BioCat GmbH
- Antibody Design Labs
- Oak BioSciences, Inc.
- Rockland Immunochemicals, Inc
- Hybrigenics Services
- neoclone biotechnology intenational LLC
February 2022: The Rockland immunochemical Inc. announced acquisition of antibodies online GmbH. The acquisition was aimed to bring both scale and supply chain stability to Rockland offerings.
April 2022: BioCat GmbH was acquired by AddLife. The acquisition was aimed to expand the portfolio in life science research market.
July 2020: The Creative Biolabs developed 400 types of therapeutic antibodies that can be applied to the study on COVID-19.
December 2018: The antibody design lab launched ALTHEA Gold libraries. These libraries are large semisynthetic single-chain libraries and they are enriched in stable and developable antibodies for therapeutic applications.